scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0968-0896(00)00016-X |
P698 | PubMed publication ID | 10819167 |
P2093 | author name string | S H Kim | |
J A Katzenellenbogen | |||
P2860 | cites work | Nonisomerizable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes | Q68417319 |
Bis (p-acetoxyphenyl) cyclohexylidenemethane(F6066), a non-steroidal compound with pronounced effects on the reproductive system | Q72750203 | ||
New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands | Q73183280 | ||
EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta | Q74013231 | ||
Facile geometric isomerization of phenolic non-steroidal estrogens and antiestrogens: limitations to the interpretation of experiments characterizing the activity of individual isomers | Q93579746 | ||
Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen | Q27766417 | ||
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 | ||
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta | Q28304508 | ||
Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (.+-.)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]-1,2-propanediol and characterization and synthesis of a biologically important metabolite | Q28329199 | ||
Rapid chromatographic technique for preparative separations with moderate resolution | Q29391396 | ||
The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site | Q34419702 | ||
The future of new pure antiestrogens in clinical breast cancer | Q40920558 | ||
Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses | Q41112992 | ||
2,3-Diarylindenes and 2,3-diarylindenones: synthesis, molecular structure, photochemistry, estrogen receptor binding affinity, and comparisons with related triarylethylenes | Q42214458 | ||
1,2-bis(4-Hydroxyphenyl)-3,4-dihydro-6-hydroxynaphthalene, a photofluorogenic ligand for the estrogen receptor | Q42220794 | ||
1,2-Diaryl-3,4-dihydronaphthalenes: photofluorogenic ligands for the estrogen receptor | Q42230288 | ||
Comparative QSAR analysis of estrogen receptor ligands | Q46485077 | ||
Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow | Q47842230 | ||
Photoaffinity labels for estrogen binding proteins of rat uterus | Q47954177 | ||
1-Benzyl-2-phenylindole- and 1,2-diphenylindole-based antiestrogens. Estimation of agonist and antagonist activities in transfection assays | Q48001030 | ||
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography. | Q52552041 | ||
Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction. | Q53962333 | ||
A one-step alternative to the Grignard reaction | Q56611053 | ||
11.beta.-Methoxy-, 11.beta.-ethyl, and 17.alpha.-ethynyl-substituted 16.alpha.-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity | Q67677251 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 785-793 | |
P577 | publication date | 2000-04-01 | |
P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
P1476 | title | Triarylethylene bisphenols with a novel cycle are ligands for the estrogen receptor | |
P478 | volume | 8 |
Q52025325 | A validation study on the practical use of automated de novo design. |
Q34109712 | Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agents |
Q42438081 | De novo design, synthesis and evaluation of a non-steroidal diphenylnaphthyl propylene ligand for the estrogen receptor |
Q34466243 | Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities |
Q41829975 | Effect of the amino chain length and the transformation into citric acid salts of aryl-diphenyl-butenes and ferrocenyl-diphenyl-butenes bearing two dimethylaminoalkyl chains on their antimicrobial activities. |
Q36781304 | Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor |